Claims for fertility drugs are up 21% in five years, but fewer than 1% of Manulife plan sponsors cover clinic treatments ...
Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results